Myomo (MYO) Cash & Equivalents (QoQ) (2016 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Myomo | 44.63 Mn | 26.23 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 12.57% |
| Sep 30, 2025 | -14.11% |
| Jun 30, 2025 | -27.53% |
| Mar 31, 2025 | -18.50% |
| Dec 31, 2024 | 253.65% |
| Sep 30, 2024 | 19.70% |
| Jun 30, 2024 | 7.57% |
| Mar 31, 2024 | -20.91% |
| Dec 31, 2023 | -0.59% |
| Sep 30, 2023 | -22.83% |
| Jun 30, 2023 | -3.31% |
| Mar 31, 2023 | 73.28% |
| Dec 31, 2022 | -27.76% |
| Sep 30, 2022 | -27.71% |
| Jun 30, 2022 | -20.91% |
| Mar 31, 2022 | -16.63% |
| Dec 31, 2021 | 23.14% |
| Sep 30, 2021 | -8.46% |
| Jun 30, 2021 | -20.72% |
| Mar 31, 2021 | 41.91% |
| Dec 31, 2020 | -8.08% |
| Sep 30, 2020 | 24.08% |
| Jun 30, 2020 | -21.81% |
| Mar 31, 2020 | 207.39% |
| Dec 31, 2019 | 3.17% |
| Sep 30, 2019 | -35.10% |
| Jun 30, 2019 | -27.78% |
| Mar 31, 2019 | 41.17% |
| Dec 31, 2018 | -28.07% |
| Sep 30, 2018 | -22.17% |
| Jun 30, 2018 | -17.23% |
| Mar 31, 2018 | 8.93% |
| Dec 31, 2017 | 161.38% |
| Sep 30, 2017 | -30.27% |
| Jun 30, 2017 | 791.93% |
| Mar 31, 2017 | 0.00% |
| Dec 31, 2016 | 61.63% |
| Sep 30, 2016 | -23.43% |